| Literature DB >> 35184585 |
Penchan Sittipreechachan1, Panan Pichayapinyo1, Sunee Lagampan1, Rewadee Chongsuwat1.
Abstract
BACKGROUND: Diabetes mellitus is increasing and a shortage exists of nurses to care for patients. Community health volunteers (CHVs) pose potential supportive networks in assisting patients to perform healthy behaviors. AIM: The study aimed to develop and investigate the effects of a CHV involvement program on reducing glycated hemoglobin (HbA1c) levels among Thai patients with uncontrolled type 2 diabetes.Entities:
Keywords: King’s General Systems Framework; community health volunteer; glycated hemoglobin; mixed-method; type 2 diabetes
Mesh:
Substances:
Year: 2022 PMID: 35184585 PMCID: PMC8864256 DOI: 10.1177/21501319221077960
Source DB: PubMed Journal: J Prim Care Community Health ISSN: 2150-1319
Baseline T2DM Patients’ Characteristics.
| Characteristics | Total (n = 60) | Intervention group (n = 30) | Comparison group (n = 30) |
|
|---|---|---|---|---|
| Female, n (%) | 41 (68.3) | 18 (60.0) | 23 (76.7) | .27
|
| Age (years), n (%) | ||||
| 35-60 | 15 (25.0) | 8 (26.7) | 7 (23.3) | .17
|
| >60 | 45 (75.0) | 22 (73.3) | 23 (76.7) | |
| Min-Max (mean ± SD) | 38-80 (65.9 ± 9.9) | 38-80 (65.6 ± 11.6) | 48-80 (66.3 ± 8.1) | .27
|
| Married, n (%) | 33 (55.0) | 17 (56.7) | 16 (53.3) | .82
|
| Education, n (%) | ||||
| Primary school | 46 (76.7) | 21 (70.0) | 25 (83.4) | .36
|
| High school and greater | 14 (23.3) | 9 (30.0) | 5 (16.6) | |
| Duration of DM (years), n (%) | ||||
| ≤10 | 29 (48.3) | 15 (50.0) | 14 (46.7) | .79
|
| >10 | 31 (51.7) | 15 (50.0) | 16 (53.3) | |
| Min-Max (mean ± SD) | 1-44 (14.9 ± 11.2) | 1-35 (14.6 ± 11.6) | 1-44 (15.2 ± 12.5) | .24
|
| HbA1c level (%), n (%) | ||||
| 7-7.9 | 47 (78.3) | 24 (80.0) | 23 (76.7) | .75
|
| ≥8 | 13 (21.7) | 6 (20.0) | 7 (23.3) | |
| Min-Max (mean ± SD) | 7.1-9.2 (7.6 ± 0.6) | 7.1-9.2 (7.6 ± 0.6) | 7.1-9.0 (7.5 ± 0.6) | .84
|
| FBG level (mg/dL), n (%) | ||||
| 80-129 | 20 (33.3) | 12 (40.0) | 8 (26.7) | .27
|
| ≥130 | 40 (66.7) | 18 (60.0) | 22 (73.3) | |
| Min-Max (mean ± SD) | 102-277 (146.9 ± 34.3) | 102-277 (148.0 ± 38.5) | 107-241 (145.8 ± 30.2) | 41
|
| Diabetes knowledge | 14.0 (3.1) | 13.9 (4.0) | .97
| |
| Self-efficacy for glycemic control | 36.7 (10.0) | 35.9 (9.9) | .77
| |
| Perceived family and CHVs support | 12.5 (5.4) | 13.0 (4.0) | .98
| |
| Behavior for glycemic control | 21.7 (4.5) | 21.3 (5.6) | .76
| |
Abbreviations: FBG, fasting blood glucose; SD, standard deviation.
Chi-square test.
Independent t-test.
Study Outcomes Within and Between Groups.
| Variables | Intervention group | Comparison group | MD (SD) between groups |
| Cohen’s | ||
|---|---|---|---|---|---|---|---|
| Mean (SD) | MD (SD) within group | Mean (SD) | MD (SD) within group | ||||
| Diabetes knowledge | |||||||
| Baseline | 14.0 (3.1) | 13.9 (4.0) | 0.1 (0.9) | .97 | |||
| 20 weeks | 22.9 (1.0) | 14.1 (3.1) | 8.8 (0.6) | <.001 | 3.8 | ||
| | <.001 | 8.9 (3.0) | .81 | 0.2 (3.7) | |||
| Self-efficacy for glycemic control | |||||||
| Baseline | 36.7 (10.0) | 35.9 (9.9) | 0.8 (2.6) | .77 | |||
| 20 weeks | 56.8 (8.0) | 35.3 (9.6) | 21.5 (2.3) | <.001 | 2.4 | ||
| | <.001 | 20.1 (8.4) | .56 | −0.6 (5.2) | |||
| Perceived family and CHV support | |||||||
| Baseline | 12.5 (5.4) | 13.0 (4.0) | −0.5 (1.2) | .98 | |||
| 20 weeks | 24.8 (6.0) | 14.4 (2.9) | 10.4 (1.2) | <.001 | 2.2 | ||
| | <.001 | 15.3 (5.7) | .24 | 0.9 (3.9) | |||
| HbA1c level | |||||||
| Baseline | 7.6 (0.6) | 7.5 (0.6) | 0.1 (0.1) | .84 | |||
| 20 weeks | 7.2 (0.4) | −0.4 (0.4) | 7.8 (0.7) | 0.3 (0.4) | −0.6 (0.2) | <.001 | 1.1 |
| | <.001 | .001 | |||||
| Behavior for glycemic control | |||||||
| Baseline | 21.7 (4.5) | 21.3 (5.6) | 0.4 (1.3) | .76 | |||
| 20 weeks | 35.4 (6.3) | 21.0 (5.5) | 14.4 (1.5) | <.001 | 2.4 | ||
| | <.001 | 13.8 (5.9) | .67 | −0.3 (3.4) | |||
| Diet | |||||||
| Baseline | 11.2 (2.0) | 10.6 (2.9) | 0.6 (0.6) | .38 | |||
| 20 weeks | 17.0 (2.6) | 10.5 (2.2) | 6.5 (0.6) | <.001 | 2.7 | ||
| | <.001 | 5.9 (2.2) | .85 | −0.1 (1.9) | |||
| Physical activity | |||||||
| Baseline | 8.5 (1.9) | 7.4 (1.8) | 1.1 (0.5) | .02 | |||
| 20 weeks | 11.2 (2.4) | 6.9 (1.8) | 4.3 (0.6) | <.001 | 2.0 | ||
| | <.001 | 2.7 (2.3) | .14 | −0.5 (1.9) | |||
| Medication adherence | |||||||
| Baseline | 16.9 (2.7) | 18.2 (2.6) | −1.3 (0.7) | .07 | |||
| 20 weeks | 22.2 (2.8) | 18.6 (2.9) | 3.6 (0.6) | <.001 | 1.3 | ||
| | <.001 | 5.2 (3.1) | .27 | 0.3 | |||
Abbreviations: MD, mean difference; SD, standard deviation.
Paired t-test.
Independent t-test.
P < .05. **P < .001.
Figure 1.Changes in HbA1c level of intervention and comparison groups.